As of 2026-02-28, the Intrinsic Value of Olema Pharmaceuticals Inc (OLMA) is -9.53 USD. This OLMA valuation is based on the model Peter Lynch Fair Value. With the current market price of 24.20 USD, the upside of Olema Pharmaceuticals Inc is -139.39%.
Based on its market price of 24.20 USD and our intrinsic valuation, Olema Pharmaceuticals Inc (OLMA) is overvalued by 139.39%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.53 - -9.53 | -9.53 | -139.39% |
| P/E | (43.08) - (46.33) | (45.61) | -288.5% |
| DDM - Stable | (11.59) - (33.46) | (22.53) | -193.1% |
| DDM - Multi | (8.93) - (20.61) | (12.53) | -151.8% |
| Market Cap (mil) | 1,903.57 |
| Beta | 0.18 |
| Outstanding shares (mil) | 78.66 |
| Enterprise Value (mil) | 1,871.31 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.32% |
| Cost of Debt | 5.00% |
| WACC | 7.99% |